Bionano Genomics

-$0.18 (-3.37%) Today
+$0.04 (+0.78%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNGO and other ETFs, options, and stocks.

About BNGO

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.

CEO
Robert Erik Holmlin
Employees
147
Headquarters
San Diego, California
Founded
2003

BNGO Key Statistics

Market Cap
1.44B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.96M
High Today
$5.42
Low Today
$5.14
Open Price
$5.40
Volume
5.85M
52 Week High
$15.69
52 Week Low
$0.4739

BNGO News

BenzingaOct 13

International Paper Plans $2B Share Buyback; Slashes Dividend By 9.8%

SmarterAnalyst Shares of genome analysis company Bionano Genomics, Inc. (BNGO) jumped 4.9% on Tuesday and closed at $5.40 in extended trade after the company a
BenzingaOct 12

What's Up With Bionano Genomics Today?

Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading higher Tuesday after the company announced it agreed to buy BioDiscovery Inc, a provider of software for
MarketWatchOct 12

Bionano Genomics to Buy BioDiscovery for Up to $100 Million

By Colin Kellaher Bionano Genomics Inc. on Tuesday said it agreed to buy BioDiscovery Inc., a provider of software for analysis, interpretation and reporting o

BNGO Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure